Forty patients with retinal vein occlusion were studied to investigate possible mech anisms leading to an acute rise in intraocular pressure. A rise in intraocular pressure on recumbency was found in 64 % of eyes with a central retinal vein occlusion and 65% of eyes with a branch retinal vein occlusion. This finding correlated with glu cose tolerance test score, and may be the result of abnormal glucose tolerance in these patients.
The pathogenesis of retinal vein occlusion is multifactorial, I clinical and experimental evi dence has stressed the role of reduced retinal perfusion.I. 3 Patients who have suffered a ret inal vein occlusion have been shown to have reduced retinal artery pressure on ophthal modynometry,3 and in experimental animals the ischaemic type of retinal vein occlusion could only be produced if the retinal artery was occluded. 4 Retinal artery perfusion pres sure may be reduced by either a fall in systemic blood pressure or a rise in intra ocular pressure (lOP). This prompted us to look at three possible mechanisms in which acute elevations in lOP may occur in patients with retinal vein occlusion. We have assessed the posturally induced change in lOP, angle closure 'risk' with pilocarpine and phenyl ephrine (P & P) provocative testing, and also pigment release into the anterior chamber with subsequent rise in lOP following pro vocative testing.
Materials
Patients who had suffered a retinal vein occlu sion and were attending the out-patients clin ics of St Paul's Eye Hospital Liverpool during the months of January to May 1984 were recruited to the study. These patients were required to attend on several occasions to have the tests performed. Any patient who was unable to fulfil this requirement was not included. Patients who were taking drugs known to affect lOP were excluded from the study. None of the patients entering the study were known diabetics. All patients gave informed consent, and ethical committee approval had been obtained.
An age and sex matched group of subjects for the standing and lying lOP part of the study were recruited as controls.
Patients were divided into three groups: Group 1. Twelve men and eight women who had suffered a CRVO. Their ages ranged from 41 to 79 years, (mean = 64 years). The time from onset of symptoms to entry into the study ranged from two days to 26 weeks, (mean = 7.5 weeks). One patient had had his fellow eye enucleated as a child. Group 2. Ten men and ten women who had suffered a BRVO. Their ages ranged from 37 to 71 years, (mean = 61 years), and the time from onset of symptoms to entry into the study ranged from one week to 52 weeks, (mean = 17.3 weeks). Group 3. Ten men and ten women control subjects with no history of eye disease or general medical condition, recruited from relatives of patients with minor complaints attending the eye hospital. Their ages ranged from 32 years to 77 years (mean = 62 years).
Methods
Each subject underwent the following investigations.
(1) Postural change in lOP was measured. After instillation of topical anaesthetic and fluorescein dye, the patient was asked to stand upright, breathing normally, and lOP was measured in both eyes using a Perkins hand held applanation tonometer, the mean of three readings was recorded. The subject was then asked to lie on a couch and after two min utes in the supine position the lOP was again measured in both eyes in a similar fashion. (2) Slit lam p biomicroscopy Using a Haag Streit 900 slit lamp, the anterior segment of the eye was examined. Particular attention was paid to the presence of lens cap sular pseudoexfoliation, iris transillumination defects, pigmentary changes in the pupil mar gin or a Kruchenberg spindle. Central anterior chamber depth was then measured using a Goldmann Pachometer. Initial lOP was recorded using a Goldmann applanation tonometer. Following this 2% pilocarpine and 10% phenylephrine (P&P) drops were simultaneously instilled, one drop of each was instilled into each eye every min ute for three applications. At 30 minute inter vals for the next two hours lOP was measured and the anterior segment examination repeated, and the presence of any pigment in the aqueous recorded. Instillation of P&P was repeated in the fashion described above at the end of the first hour. At the end of the Second hour the study was terminated with the instill ation of 0.5% thymoxamine drops. (4) Glucose tolerance test On a separate occasion, following an over night fast, the patient was asked to drink 50 g of glucose. Blood was taken for serum glucose estimation before and two hours after inges tion of the glucose. A two hour blood glucose level of less than 6.1 mmolll was taken as normal, 6.1-10 mmolll showed impaired glucose tolerance and greater than 10 mmol/l indicated diabetes.
Results

Intraocular pressure
Baseline lOPs recorded in the sitting position prior to P&P testing showed the lOP of the affected eye to be lower than the fellow eye in 53% of CRVO patients and 40% of BRVO patients.
In patients with CRVO the lOP levels in affected eyes were significantly lower than fel low eyes (paired t = 2.42, p<0.05), whereas the lOPs did not signficantly differ in patients with BRVO (paired t = 1.56, P = 0.13). In the control subjects there was no significant inter-eye lOP difference (paired t = 0.75, P =0.46). There was a low correlation between inter-eye' lOP difference and dura tion of occlusion for both CRVO patients (r = 0.44, P = 0.06) and BRVO patients (r = 0.09, P = 0.72).
Eight eyes (from 5 patients) in the CRVO group and only one eye in the BRVO group had an lOP of greater than 21 mmHg. None of the controls had an lOP greater than 21mmHg.
The change in lOP induced by recumbency was calculated by subtracting the standing lOP from the lying lOP measurement. The results are shown in Figure 1 . In the retinal vein occlusion group there was a significantly greater lOP rise induced by recumbency than controls.
In the CRVO group the mean rise in lOP was significantly greater in both affected and fellow eyes compared with controls. The mean rise in affected eyes was 3.4 ± 2.4 (SD) mmHg (unpaired t=5.96, p<O.OOOl) and in the fellow eyes 3.7±3 (SD) mmHg (unpaired SIL lOP mmHG t = 5.64, p<O.OOO1). In the BRVO the mean rise in lOP was also significantly greater in both affected and fellow eyes compared with controls. The mean rise in affected eyes was 3.3 ± 3.0 (SD) mmHg (unpaired t = 4.59, p<O.OOO1) and in fellow eyes 4.1 ± 2.4 (SD) mmHg (unpaired t = 7.72, p<O.OOOl). There was no significant difference for lOP rise between affected and fellow eyes for either the CRVO or BRVO groups. There was a low correlation between the postural lOP change in affected and fellow eyes in both CRVO (r = 0.33, P = 0.17) and BRVO (r = 0.39, P = 0.09) groups. On the other han d , the postural lOP change in right and left control group eyes was closely corre lated (r = 0.63, P = 0.003).
Glucose tolerance test
Two out of 20 patients in the CRY 0 group and one out of 20 patients in the BRVO group were found to be diabetic, and three patients in the CRVO group and four patients in the BRVO group had impaired glucose tolerance.
A correlation of postural lOP change was sought with glucose tolerance, duration of occlusion and age. A high correlation was only found for glucose tolerance test results with both CRVO fellow eyes (r = 0.6, P = 0.014) and BRVO affected eyes (r = 0.66, P = 0.002). After pooling the affected eyes and fellow eyes postural lOP change from both vein occlusion groups and correlating these two pooled groups with glu cose tolerance test scores a significant correla tion for affected eyes (r=0.387, p=0.0l4) and fellow eyes (r = 0.463, p = 0.003) was found.
Anterior chamber depth
The anterior chamber depths for CRVO patients ranged from 2.1 mm to 3.2 mm (mean = 2.6 mm) in the affected eye and 2 mm to 3.4 mm (mean = 2.6 mm) in the fel low eye. The BRVO patients ranged from 1.9 mm to 3.2 mm (mean = 2.5 mm) in the affected eye and 2 mm to 3.3 mm (mean = 2.5 mm) in the fellow eye.
Anterior segment examination
Forty-eight eyes (61 %) (22/39 in the CRVO group and 26/40 in the BRVO group) had anomalies in the pigment layer of the iris. Pig ment fall-out in the collarette was the most frequent anomaly noted, a large number had small areas of iris transillumination defects and only one patient (in the CRVO group) had a Kruckenberg spindle. No patient had pseudoexfoliation.
Provocative testing with Pilocarpine and Phenylephrine
No eye developed a positive provocative test (an evaluation of lOP greater than 8 mm Hg or irido-corneal contact).
Following provocative testing 65% of affected eyes and 63% of fellow eyes in the CRVO group showed substantial pigment release into the anterior chamber. The BRVO group showed a similar response with 55% of affected and 60% of fellow eyes releasing pig ment into the anterior chamber. In nearly all cases the eye had previously been noted to have iris pigment anomalies.
The results of provocative testing in relation to pigment release and lOP change are shown in Figure 2 . Overall 52% of CRVO eyes and 71 % of BRVO eyes that released pigment showed a rise in lOP.
The patients in the CRVO group who released pigment showed a significantly greater lOP rise compared with those who did not (unpaired t = 2.07, p<0.05). A similar difference was shown for BRVO patients (unpaired t = 2.51, p<0.05). Three out of the 39 patients showed a unilateral release of pig ment (excluding the CRVO patient with only one eye).
Discussion
Vannas in 19605 reported five cases of angle closure glaucoma associated with retinal vein occlusion. In three of the cases the retinal vein occlusion was diagnosed at the time of the acute attack. Although provocative testing was performed, it was limited to those patients who gonioscopically did not have narrow angles, or in whom there were no records of previous acute attacks. One finding known to be associated with angle closure glaucoma is a shallow anterior chamber. Our results show that the anterior chamber depths of patients wtih retinal vein occlusion lie within the normal range for age matched con trols,6 and outside the range of patients with angle closure. The result of provocative test ing wtih P&P was negative in all patients. We feel therefore that there is unlikely to be an association or causal relationship between angle closure -(pupil block) and retinal vein occlusion.
Anomalies in the iris pigment epithelium were found in 48/79 retinal vein occlusion eyes (61 %). The incidence of this in the normal population has not been defined. They may represent areas where pigment has already been shed into the anterior chamber, this speculation is further supported by the finding of pigment release into the anterior chamber on provocative testing with P&P in patients who also showed iris pigment anomalies. Pig ment release was found in over 50% of affected and fellow eyes, the incidence in normal subjects varies between 5% and 27% .7 The mean lOP rise in patients releasing pig ment was significantly greater than those who did not !"e1ease pigment. Pigment as it leaves the anterior chamber may block the trabec ular meshwork causing an acute rise in lOP, especially if the facility for outflow is already compromised. H Williams et al. 9 when testing for a relationship between outflow facility and abnormal postural rise in lOP, found outflow facility to be reduced in some patients with retinal vein occlusion, although they failed to demonstrate any association between the two. Despite this, differences in outflow facility may have been a factor why not all our patients who released pigment showed a rise in lOP, although outflow facility was not measured in our group. The presence or absence of pigment release was bilateral in 36/39 patients (excluding the patient with only one eye). This suggests that the phenomenon of pigment release probably predated the ret-lOP Change mmHG
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.. inal vein occlusion. Cases of spontaneous release of pigment in response to exercise ,1 0 dim illumination or emotion, II which when these conditions were duplicated experimen tally caused an increase in lOP, are well known. Although provoking the release of pigment is not physiological, it was found to be associated with anomalies in the pigment layer of the iris suggesting these patients had already demonstrated pigment release in the past. Whether the anomalies of the iris pig ment epithelium observed in our patients represents the previous loss of pigment in intermittent showers, perhaps associated with a rise in lOP, or a continuous loss of small amounts is not known. It has been previously reported that in CRVO the lOP in the affected eye may be lower than the fellow eye, the mechanisms proposed for this are speculativel2 and our results confirm this observation but do not suggest any explanation for this finding.
We confirmed the finding that patients with retinal vein occlusion have a greater elevation in lOP on recumbency than normal sub jects.12.14 The underlying mechanism is prob ably one of impaired auto-regulation and it is thought that on recumbency episcleral venous pressure becomes elevated, with consequent elevation in lOP. It is interesting that both eyes of patients with retinal vein occlusion show a rise in lOP on recumbency. This sug gests that the abnormal finding probably pre dated the occlusive rather than was a consequence of it. This breakdown in home ostatic control is further reinforced by the low correlation found for lOP change on recum bency between eyes in the retinal vein occlu sion patients against the high correlation found in the controls. However, the high cor relation between postural lOP change and glucose tolerance test score suggests that this abnormal finding may result from the abnormal glucose tolerance found in this study group.
Our results suggest two possible mechan isms by which lOP may rise in retinal vein occlusion. Firstly on recumbency and secondly from pigment release. The bilateral ity of these responses suggests that they prob ably predate the occlusion, therefore may have been important in setting in motion the train of events leading to the retinal vein occlusion.
